Viewing Study NCT00461851


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-02-01 @ 11:07 PM
Study NCT ID: NCT00461851
Status: COMPLETED
Last Update Posted: 2017-12-14
First Post: 2007-04-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
Sponsor: Yale University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced/Metastatic Bladder Carcinoma View